In silico bioavailability for BCS class II efavirenz tablets using biorelevant dissolution media for IVIVR and simulation of formulation changes-Reference-Cited by-同舟云学术

In silico bioavailability for BCS class II efavirenz tablets using biorelevant dissolution media for IVIVR and simulation of formulation changes

Published:2021-10-21 Issue: Volume: Page:1-11
ISSN:0363-9045
Container-title:Drug Development and Industrial Pharmacy
language:en
Short-container-title:Drug Development and Industrial Pharmacy

Author:

Silva Thalita Martins da¹²^ORCID,Honorio Thiago da Silva³^ORCID,Chaves Marcelo Henrique da Cunha¹^ORCID,Duque Marcelo Dutra⁴^ORCID,Cabral Lucio Mendes³^ORCID,Patricio Beatriz Ferreira de Carvalho¹^ORCID,Rocha Helvécio Vinícius Antunes¹²^ORCID

Affiliation:

1. Farmanguinhos, Laboratório de Micro e Nanotecnologia, Rio de Janeiro, Brasil

2. Pesquisa e Desenvolvimento na Indústria Farmacêutica, Farmanguinhos, Programa de Pós-graduação Profissional em Gestão, Rio de Janeiro, Brazil

3. Laboratório de Tecnologia Industrial Farmacêutica, Faculdade de Farmácia, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil

4. Laboratório de Farmacotécnica e Cosmetologia, Instituto de Ciências Ambientais, Químicas e Farmacêuticas, Universidade Federal de São Paulo, Diadema, Brazil

Funder

Funda??o Carlos Chagas Filho de Amparo ? Pesquisa do Estado do Rio de Janeiro

Fundação Oswaldo Cruz

Brazilian Development Bank

Publisher

Informa UK Limited

Subject

Organic Chemistry,Drug Discovery,Pharmaceutical Science,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/03639045.2021.1991368

Reference47 articles.

1. Fundamentals of Dissolution

2. The Use of Biorelevant Dissolution Media to Forecast the In Vivo Performance of a Drug

3. Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards

4. Validation of Dissolution Testing with Biorelevant Media: An OrBiTo Study

5. Predicting the oral absorption of a poorly soluble, poorly permeable weak base using biorelevant dissolution and transfer model tests coupled with a physiologically based pharmacokinetic model